Chief Business Strategy Officer
Mr. Hedt is an experienced research professional with over 20 years in the biotechnology and pharmaceutical industries and a comprehensive understanding of all stages of drug research, development, and product innovation.
He has extensive experience and knowledge managing clinical projects with a concentration in early-stage drug development specializing in theranostics, radiopharmaceuticals, mAbs, and vaccines. Mr. Hedt joins the Perspective Therapeutics team having most recently served as the Chief Business Strategy Officer at Viewpoint Molecular Targeting. Prior to that he was the Founder and Principal Consultant at Cedalion, a strategic consulting and contract research practice specializing in the biotechnology, pharmaceutical, and diagnostic industries, working to provide strategic development plans, analysis of database and literature, and insight into the competitive landscape for an optimized approach to novel developments. Prior to that, he served as Head of Clinical Development and Strategy for Clarity Pharmaceuticals Ltd., a clinical-stage radiopharmaceutical company developing theranostics for the diagnosis and therapy of cancer, where he played a vital role in the design and implementation of clinical trial programs that drove research and development strategies and advancements. Additionally, Mr. Hedt served as Senior Director, Clinical Operations for Patrys Ltd., a clinical-stage biotechnology company focused on the development of an entirely new type of product for the treatment of cancer – natural human antibodies. He also held a variety of roles at CSL Ltd., an Australian multinational specialty biotechnology company that researches, develops, manufactures, and markets products to treat and prevent severe human medical conditions. Mr. Hedt received his Bachelor of Arts in Psychophysiology and Psychology from the Swinburne University of Technology and completed his Graduate and Postgraduate training in the History and Philosophy of Science at the University of Melbourne.